PlainRecalls
FDA Devices Moderate Class II Ongoing

t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM, and t:slim X2 Insulin Pump with Basal-IQ Technology

Reported: June 22, 2022 Initiated: September 10, 2020 #Z-1258-2022

Product Description

t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM, and t:slim X2 Insulin Pump with Basal-IQ Technology

Reason for Recall

Insulin pumps may display unexpected fluctuation of the remaining battery life so ensure pump battery life does not fall below 25% remaining power. If the battery life drops to less than 5%, insulin delivery will continue for 30 minutes and then the pump will power off and insulin delivery will stop. If the battery reaches 1%, then insulin delivery will stop, which could lead to hyperglycemia.

Details

Recalling Firm
Tandem Diabetes Care Inc
Units Affected
5,206
Distribution
International distribution in the country of Australia.
Location
San Diego, CA

Frequently Asked Questions

What product was recalled?
t:slim X2 Insulin Pump with Dexcom G5 Mobile CGM, and t:slim X2 Insulin Pump with Basal-IQ Technology. Recalled by Tandem Diabetes Care Inc. Units affected: 5,206.
Why was this product recalled?
Insulin pumps may display unexpected fluctuation of the remaining battery life so ensure pump battery life does not fall below 25% remaining power. If the battery life drops to less than 5%, insulin delivery will continue for 30 minutes and then the pump will power off and insulin delivery will stop. If the battery reaches 1%, then insulin delivery will stop, which could lead to hyperglycemia.
Which agency issued this recall?
This recall was issued by the FDA Devices on June 22, 2022. Severity: Moderate. Recall number: Z-1258-2022.